H
Hong Kong Asia Heart Centre (Wuhan Asia Heart Hospital)
Hong Kong Asia Medical Group originated in 1999. Since the establishment of its first hospital, Wuhan Asia Heart Hospital, it has been at the forefront of the development of cardiovascular disciplines
About Hong Kong Asia Heart Centre (Wuhan Asia Heart Hospital)
Hong Kong Asia Medical Group, which originated in 1999 with the establishment of its first hospital, Wuhan Asia Heart Hospital, has become a significant player in the cardiovascular healthcare sector in China. The hospital was founded by Tse Chun-ming.
Wuhan Asia Heart Hospital, a tertiary cardiology hospital, was established on November 11, 1999. The hospital has a capacity of 750 beds and provides a comprehensive range of services for cardiovascular diseases. These services include cardiac health check-ups, consultations, and advanced surgical procedures like angioplasty. The institution has gathered a team of domestic cardiovascular disease diagnosis and treatment experts, enabling it to perform a variety of complex cardiac operations.
A key milestone for the hospital was in January 2018, when it passed the evaluation for a Class A hospital in China. The group has also expanded its footprint by acquiring the Xinjiang Cardio-cerebrovascular Hospital in 2010 and establishing heart partnership centers in various cities between 2015 and 2017. In 2018, the global growth equity firm General Atlantic invested $150 million into the holding company, signaling confidence in its business model of operating specialized cardiovascular hospitals and clinics.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 103
- Open positions
- None listed
- Dealroom signal
- 68.3/100
- Industry
- Health
- Sector
- Cardiology and cardiovascular, Hospital, Rumoured $1B, Hard Tech
- Client focus
- B2C
- Investment activity
- 1 company, latest Jul 2023
- Capital deployed
- $20M
- Preferred round
- SERIES A
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Feb 2022 | $400M | $1.6B | General Atlantic · Hudson Bay Capital Management · ABC International · ICBC International | ↗ |
| SERIES COther financing | Sep 2018 | $150M | $600M | General Atlantic | — |
Growth signals
Latest recorded traffic for Hong Kong Asia Heart Centre (Wuhan Asia Heart Hospital) is 510 monthly website visits, down 76.8% over the last three months. Hong Kong Asia Heart Centre (Wuhan Asia Heart Hospital)'s team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
SimbionixProvides simulation, training, and education solutions for medical professionals and the healthcare industry |
Lod, Israel | Acquired | 4 | $7.3M | $120M |
InspireMDStent System Technology for Preventing Embolization |
Tel Aviv-Yafo, Israel | Operational | |||
Paieon MedicalProgressive Cardiac Navigation Imaging Solutions |
Rosh Haayin, Israel | Operational | |||
NepheraKidney Function Protection in Heart Failure Patients |
Caesarea, Israel | Operational | |||
Biosense WebsterDiagnosis and Treatment of Cardiac Arrhythmias |
Tirat Karmel, Israel | Low Activity | |||
Medical SolutionsBest Travel Nursing Company & Staffing Agency - Medical Solutions |
Omaha, United States | Acquired | |||
BioGenCellUses stem cells from the patient’s own blood to treat microvascular diseases and designs cellular therapies |
Hod Hasharon, Israel | Operational | |||
| Netanya, Israel | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Hong Kong Asia Heart Centre (Wuhan Asia Heart Hospital) in the Wuhan ecosystem
The Hong Kong Asia Heart Centre (Wuhan Asia Heart Hospital) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later10 investors entered at this stage
General Atlantic- CCCountry Garden Venture Capital
Primavera Capital Group
Hudson Bay Capital Management- AIABC International
ICBC International- SISherpa Investment
Legend Capital
Taikang Life Insurance
BOCOM International
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hong Kong Asia Heart Centre (Wuhan Asia Heart Hospital) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hong Kong Asia Heart Centre (Wuhan Asia Heart Hospital)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








